Montibon, Shane Xaira C.

HRN: 22-41-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2023
CEFUROXIME 750MG (VIAL)
06/24/2023
07/01/2023
IVT
190MG
Q8
PCAP-C
Waiting Final Action 
06/27/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/27/2023
07/01/2023
PO
2.4ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: